All (N=102) | CAD-score <20 (N=43) | CAD-score ≥20 (N=59) | P value | Adjusted CAD-score <20 (N=10) | Adjusted CAD-score ≥20 (N=65) | P value | |
Age, years (range) | 58.5 (46.9–72.1) | 61.0 (53.0– 73.8) | 55.0 (43.2– 71.0) | 0.17 | 42.5 (34.0– 46.2) | 62.0 (52.3– 73.3) | <0.001 |
Male no (%) | 68 (66.7) | 26 (60.5) | 42 (71.2) | 0.36 | 4 (40.0) | 50 (76.9) | 0.041 |
Hypertension no (%) | 61 (59.8) | 32 (74.4) | 29 (49.2) | 0.018 | 2 (20.0) | 43 (66.2) | 0.015 |
Hyperlipoproteinaemia no (%) | 29 (28.4) | 14 (32.6) | 15 (25.4) | 0.57 | 0 (0) | 23 (35.4) | 0.059 |
Ever smoker no (%) | 40 (39.6) | 19 (44.2) | 21 (36.2) | 0.55 | 4 (40.0) | 26 (40.0) | 1.00 |
Diabetes no (%) | 8 (7.8) | 8 (18.6) | 0 (0) | 0.0021 | 0 (0) | 6 (9.2) | 0.71 |
Family history of CAD no (%) | 24 (24.2) | 9 (20.9) | 15 (26.8) | 0.66 | 5 (50.0) | 16 (25.4) | 0.22 |
History of CAD/bypass/PCI no (%) | 25 (24.5) | 12 (27.9) | 13 (22.0) | 0.65 | 0 (0) | 20 (30.8) | 0.096 |
Baseline characteristics of the study population. P values comparing the CAD-score groups (unadjusted < vs ≥ 20 and adjusted < vs ≥ 20); adjusted CAD-score adjusted for age, sex and hypertension.
CAD, coronary artery disease; PCI, percutaneous coronary intervention.